# PG — Changelog

*Append-only. Most recent entry first.*

---

## [2026-05-30] — No Material Events

**Lookback window**: 2026-05-10 → 2026-05-30
**Sources scanned**: IR (no new PR/8-K), SEC EDGAR (Q3 10-Q filed, corresponds to already-integrated April 24 earnings), analyst feed, short-interest aggregator, insider feed, news search

### Snapshot
- Price: $143.90 (Δ: –2.7% vs. $147.90 baseline May 6 close) — [Yahoo Finance](https://finance.yahoo.com/quote/PG)
- 52-wk range: $137.62 – $170.99 (% from high: –15.8%; +4.6% above 52-wk low)
- Short interest: ≈0.73% of float (≈17.3M shares; ≈2.4 days to cover; Δ MoM: down from ≈1.18% — modest de-risking, remains negligible)
- Analyst consensus: median ≈$163.6 (Δ: ~unchanged vs. ≈$164); Buy; no new rating actions in window (all post-Q3 actions were late-April, already captured)
- News scanned and dismissed:
  - May 15, 2026 dividend payment ($1.0885/share) executed — mechanical, anticipated catalyst; no thesis impact
  - Seeking Alpha "Priced Like A Hyper Growth Tech Stock" reiterate-Sell (overvaluation view) — opinion piece, no new data
  - GuruFocus/Morningstar undervaluation notes (GF Value $167, DCF +23%) — third-party valuation models, no primary-source event

### Snapshot read
Price drifted –2.7% to $143.90, sitting inside the $135–$148 attractive entry zone and ~4.6% above the 52-wk low. No fundamental change — drift is staples-sector softness, not PG-specific. Recommendation unchanged.

**Recommendation**: Unchanged. 🟡 Non-holder: Watch / Initiate small (in-zone at $143.90). 🟡 Holder: Hold.
**Next review trigger**: Q4 FY2026 earnings — late July 2026 (second Jejurikar confirmation print).

---

## [2026-05-10] — Capital Allocation Event (Dividend Raise) + Schema v2.9 → v2.14 Migration

**Trigger**: (1) P&G declared a +3% quarterly dividend raise on April 14, 2026 ($1.0568 → $1.0885/share), payable May 15, 2026 — a Meaningful Event (capital allocation). (2) Lazy schema migration from v2.9 to v2.14 applied per explicit orchestrator instruction.

**Sources reviewed**:
- [P&G Dividend Increase 8-K — pginvestor.com](https://www.pginvestor.com/news/news-details/2026/PG-Declares-Dividend-Increase-for-April-2026/default.aspx)
- [P&G Dividend Increase — us.pg.com](https://us.pg.com/newsroom/news-releases/PG-Declares-Dividend-Increase-for-April-2026/)
- [Yahoo Finance — PG Quote (May 6, 2026 close)](https://finance.yahoo.com/quote/PG)
- [stockanalysis.com — PG Forecast (analyst consensus)](https://stockanalysis.com/stocks/pg/forecast/)
- [Fintel — PG Short Interest](https://fintel.io/ss/us/pg)
- [Fintel — PG Insider Activity](https://fintel.io/sn/us/pg)
- No new 10-Q or earnings release in window (Q4 FY2026 expected late July 2026)

### What Changed

- **Header**: Schema v2.9 → v2.14; Last Updated bumped to 2026-05-10; Live Price updated to $147.90 (May 6 close); Dividend yield updated to ≈2.95% ($1.0885/quarter)
- **Summary**: Full rewrite to v2.14 4-part format (Rule #18) — thesis+verbs line, 5-yr scenario table (8-col), KPI strip (6-cell), Why/Why-not/Next-read bullets
- **Key Stats Snapshot**: Quarterly dividend updated $1.0568 → $1.0885; yield ≈2.85% → ≈2.95%; short interest updated to 1.18% / 5.42 days to cover; price refreshed; added Core EPS $1.59 for Q3 FY2026
- **§4 Management**: Added April 2026 dividend raise detail; resolved "dividend freeze during restructuring" as a ✅ DE-RISKED trigger
- **§5 Strategic Growth**: Added Glad JV dissolution details (Clorox paid $476M for PG's stake; $261M after-tax gain in Q3)
- **§8 Valuation**: Dividend yield updated to ≈2.95%
- **§9 Catalyst & Sentiment**: Price, consensus, and analyst actions refreshed (UBS +$172, Wells Fargo +$164, TD Cowen +$150 post-Q3); dividend raise added as ✅ delivered catalyst; May 15 dividend payment added to upcoming catalysts
- **§10 BAIT**: I (Informational) commentary updated — dividend raise during restructuring year treated as informational signal of FCF confidence
- **§11 Scenarios**: Updated to explicit 5-year terminal horizon (FY2031E) per Rule #26; Bear midpoint adjusted $125 → $120 on fuller 5-yr terminal framing
- **§12 PW EV**: Recomputed with updated Bull $185 midpoint → PW EV ≈$159.50; R/R updated to ≈1.3:1 vs. current spot
- **§13 Recommendation**: Added resolved trigger ✅ DE-RISKED [2026-04-14] for dividend freeze; updated entry/trim/exit zone commentary; exit zone expanded to $185 (matched to Bull midpoint per Rule #26)
- **Schema migration**: Rule #18 (Summary 4-part block), Rule #23 (moat detail confirmed in §3 only — was already compliant), Rule #24 (Competitive Landscape confirmed present in §3), Rule #25 (§6 materiality filter confirmed), Rule #26 (5-yr terminal horizon applied to §11; PW EV anchors §13 zones; R/R cited in Summary, §12)

### Thesis Status
- **Overall**: 🟡 **Unchanged** — dividend raise confirms capital-allocation discipline; no new fundamental deterioration; thesis trajectory modestly positive but R/R at current price remains modest
- **BAIT delta**: I (Informational) ticked marginally higher on dividend raise signal; overall Low-Moderate conviction unchanged
- **Price target delta**: Bull midpoint $180 → $185 (5-yr terminal re-anchor); Bear midpoint $125 → $120; Base unchanged $160; PW EV ≈$159 → ≈$159.50
- **R/R**: ≈1.4:1 → ≈1.3:1 (marginally lower as Bear scenario deepened slightly on 5-yr terminal reframe)

### Recommendation
- **For a non-holder**: 🟡 Watch / Initiate small at $140–$148 — dividend raise + Q3 volume growth = two confirmations; Q4 FY2026 late July is the next conviction-building event
- **For a current holder**: 🟡 Hold — do not exit; add below $145; trim at $170–$185

**Attractive entry zone**: $135–$148
**Trim zone**: $170–$185
**Exit / avoid zone**: >$185

**Next review trigger**: Q4 FY2026 earnings — late July 2026

---

## [2026-04-26] — v2.9 Retrofit + Q3 FY2026 Earnings Integration

**Trigger**: Schema migration from v2.5 (15-section structure) to v2.9 (13-section structure) + integration of Q3 FY2026 earnings results (released April 24, 2026 pre-market — beat on revenue and GAAP EPS; first volume growth in over a year).

**Sources reviewed**:
- [P&G Q3 FY2026 Press Release](https://us.pg.com/newsroom/news-releases/PG-Announces-Fiscal-Year-2026-Third-Quarter-Results/) — GAAP EPS $1.63 vs. $1.56 est; organic +3%; net sales $21.2B (+7%)
- [P&G FY2025 Annual Report — Introduction](https://us.pg.com/annualreport2025/introduction-and-fy-results/) — Moeller's final CEO letter; FY2025 organic +2%, core EPS +4%
- [stockanalysis.com — PG financials](https://stockanalysis.com/stocks/pg/financials/) — 5-year annual + 8-quarter data
- [stockanalysis.com — PG forecast](https://stockanalysis.com/stocks/pg/forecast/) — analyst consensus, rating actions
- [Fintel — PG short interest + insider](https://fintel.io/ss/us/pg) — 1.19% short float; 14 insider sells (0 buys) in 6 months
- [Yahoo Finance — PG quote](https://finance.yahoo.com/quote/PG) — $148.18 April 24, 2026 close
- raw/PG/press-releases/2026-04-Q3-results.txt (local)
- raw/PG/shareholder-letters/2025_letter.txt (local)

### What Changed

- **Schema**: v2.5 → v2.9; 15 sections → 13 sections. Section 1 (Why Exist) retired; Sections 3+4 merged into new Section 2 (Revenue Mix & Geographic Split); sections renumbered throughout.
- **Header**: Updated to v2.9, Last Updated 2026-04-26; removed stale Q3 pre-earnings notice.
- **Summary**: Refreshed for post-Q3 thesis state; updated moat verdict, recommendation verbs, BAIT verdict, next catalyst.
- **Business Overview**: Added Q3 FY2026 context (Jejurikar's second print, first volume growth in >1 year).
- **Pivotal Investment Question**: Updated to post-Q3 framing — question now shifts from binary "will volume return?" to "can Jejurikar sustain volume recovery into Q4/FY2027?"
- **Section 1 (Annual Financial Metrics)**: Added 8-quarter trend table; 5-year annual table with gross/operating margins; time-in-columns format per v2.9.
- **Section 2 (Revenue Mix & Geographic Split)**: New section merging old §3+§4; added Q3 FY2026 segment data table; geographic split; forward mix shifts.
- **Section 3 (Competitive Moat & Landscape)**: Added mandatory Competitive Landscape subsection (Rule #24) with 6 named peers, market share, P/E, and how-PG-differs analysis; removed standalone Moat Assessment block.
- **Section 4 (Management & Leadership)**: Added Recent Management Commentary subsection (Rule #19) with FY2025 Moeller letter verbatim quotes + 5-year strategic arc synthesis; added Q3 Jejurikar quotes; added Moeller $28M insider sales disclosure.
- **Section 5 (Strategic Growth Initiatives)**: From old §7; updated with Q3 Jejurikar commentary.
- **Section 6 (Key Risks)**: Applied Rule #25 materiality filter; removed generic boilerplate; added gross-margin compression as standalone risk ("not fully priced"); risk factor evolution as synthesis paragraph (Rule #21) replacing table.
- **Section 8 (Valuation)**: Updated multiples with TTM data; refreshed peer P/E table; downside/upside scenario valuations.
- **Section 9 (Catalyst & Sentiment)**: Fully refreshed with Q3 FY2026 delivered (✅), post-Q3 analyst target cuts, insider activity disclosure; upcoming catalysts updated to Q4 FY2026.
- **Section 10 (BAIT)**: Updated post-Q3; B and I both moved from Weak-Moderate to Moderate; overall signal upgraded from "Weak" to "Low-Moderate."
- **Section 11 (Bull/Bear/Base)**: Probabilities updated post-Q3: Bull 25%→30%, Bear 30%→20%; price ranges maintained.
- **Section 12 (PW EV)**: Recomputed: PW EV ~$159 vs. $148.18 = +7.3% price + 3% dividend = ~10.3% total return; R/R 1.4:1.
- **Section 13 (Recommendation)**: Updated to post-Q3 recommendation; resolved triggers marked ✅ DE-RISKED; updated thesis-break triggers.

### Thesis Status
- **Overall**: 🟡 **Cautiously Strengthened** — Q3 FY2026 volume growth is the first genuine positive signal in 6 quarters. Not yet enough for a conviction buy, but structural-deterioration bear case is weaker.
- **BAIT delta**: B Moderate → Moderate-Strong; I Weak-Moderate → Moderate; A Weak-Moderate → Moderate; T unchanged Weak. Overall: Weak → Low-Moderate
- **Price target delta**: Bull $170–185 (25%) → $175–185 (30%) | Base $155–165 (50%) unchanged | Bear $120–130 (30%) → (20%)
- **PW EV delta**: ~$154 → ~$159 (+$5 on reduced bear probability)
- **R/R**: ~1.3:1 → ~1.4:1

### Recommendation
- **For a non-holder**: 🟡 Watch / Initiate small at $140–$148 — first confirmation print received; entry zone attractive near 52-wk lows; Q4 FY2026 is the next conviction-building event
- **For a current holder**: 🟡 Hold — volume recovery supports thesis floor; add on dips below $145; trim at $170–180

**Attractive entry zone**: $135–$148
**Trim zone**: $170–$180
**Exit / avoid zone**: >$185

**Next review trigger**: Q4 FY2026 earnings — late July 2026

---

## [2026-04-24] — v2.1 Migration (Workflow A) — Single-Page Consolidation + Pre-Earnings Refresh

**Trigger**: Schema migration from v1 (4-file structure: overview/thesis/financials/changelog) to v2.1 (single consolidated `PG.md` + `changelog.md`). Live price refreshed and recommendation framework updated to highlight the **April 24, 2026 (Q3 FY2026) earnings print — TODAY (pre-market)** as the dominant binary catalyst.

**Sources reviewed**:
- Yahoo Finance JSON API (live price $148.18; 52-wk range $137.62–$170.99; verified Apr 24, 2026)
- Prior v1 wiki files (overview.md, thesis.md, financials.md, changelog.md) — folded into single PG.md
- PG_price_analysis_2026-03-25.html (prior Three-Horizon Price & Event Analysis)
- Q2 FY2026 earnings (Jan 22, 2026): EPS $1.78 vs. $1.87 expected — miss under new CEO Jejurikar
- Q3 FY2025 (Apr 24, 2025): Guidance cut citing tariffs ($1–1.5B/yr)
- CEO transition: Moeller → Jejurikar effective Jan 1, 2026
- Restructuring: 7,000 job cuts + brand divestitures + market exits ($1.5–2.0B charges over FY2026–FY2027)
- Erste Group downgrade (Mar 24, 2026)

### What Changed from Prior Entry (2026-04-06 at $143.35)

- **Live price**: $143.35 → **$148.18** (+3.4%); modest pre-earnings drift higher
- **52-week range refined**: now $137.62 – $170.99 (high revised from $174.80 reported in v1; $170.99 is the verified 52-wk-trailing high as of Apr 24, 2026)
- **Q3 FY2026 earnings is now TODAY (pre-market — imminent or just released)** (April 24, 2026) — Section 11 and Section 15 explicitly elevate this as the dominant binary catalyst
- **Recommendation framing tightened**: pre-print = Watch / Hold (do not initiate, do not exit); post-print = re-evaluate with explicit beat/in-line/miss decision tree
- **Schema migration**: Consolidated overview.md + thesis.md + financials.md → PG.md per v2.1 CLAUDE.md. Position-sizing language ("small or watch position", portfolio % framing) removed per Core Rule #3. Replaced with price-level entry/trim/exit zones and non-holder/holder split.

### Thesis Status
- **Overall**: **Unchanged** — same "show me" thesis with the central catalyst now imminent. The 7-day timeline to Q3 FY2026 means thesis status will refresh dramatically next week regardless of outcome.
- **BAIT delta**: No change pre-print
  - B: Moderate (fundamental support for the fear remains; not a clean overreaction)
  - A: Weak-Moderate (consensus appears fair at 20× for 0–4% growth)
  - I: Weak-Moderate (Q2 miss is the most recent primary data; no underappreciated edge identified pre-print)
  - T: Weak (downtrend partially repaired; +7.7% off low; binary print risk increasing volatility into earnings)
  - Overall: Weak signal, no significant overlap. Conviction Low.
- **Price target delta (1–2 yr scenarios)**: Bull $170–185 (25%) | Base $155–165 (45%) | Bear $120–130 (30%) — unchanged from prior entry
- **PW EV ~$154 vs. spot $148.18 = +4% price + ~3% dividend = ~7% total** — modest, consistent with show-me status
- **Catalyst & Sentiment delta**: April 24 print elevated to *the* catalyst. Erste downgrade (Mar 24) noted. Defensive rally ($137 → $163 in Feb) fully unwound by late March.

### Recommendation
- **For a non-holder**: **Watch** — do not initiate ahead of April 24. Pre-print binary risk + thin PW asymmetry (~7% total return) does not justify positioning. Re-evaluate within 24 hours of the print using beat/in-line/miss decision tree.
- **For a current holder**: **Hold through April 24** — do not exit at –13% off highs (forfeits upside optionality on beat); do not add until print confirms execution. Trim into strength if price >$165 post-print.

**Attractive entry zone**: $135 – $145
**Trim zone**: $170 – $180
**Exit / avoid zone**: >$185

**Thesis-break triggers**:
1. Q3 FY2026 EPS miss + organic growth ≤0%
2. FY2026 organic sales guide cut below 0%
3. Tariff headwind expansion above $1.5B for FY2026
4. Dividend cut or freeze (immediate exit)
5. Two consecutive quarters of accelerating private-label share losses
6. Restructuring savings not materializing in operating margin by Q4 FY2026
7. Jejurikar departure or material C-suite turnover
8. Multiple compression below 17× without earnings deterioration (structural staples de-rating)

**Next review trigger**: **Q3 FY2026 earnings — April 24, 2026 (pre-market). TODAY (pre-market — imminent or just released).** Mandatory full-framework refresh within 24 hours of the print.

---

## [2026-04-06] — Initial Ingest

**Trigger**: Initial compilation from raw analysis file
**Data points reviewed**:
- `raw/analyses/PG_price_analysis_2026-03-25.html` — Three-Horizon Price & Event Analysis (March 25, 2026)
- Price data: Yahoo Finance / CNBC verified at $143.35 as of March 25, 2026

### What Changed
- Initial compilation; no prior wiki entry existed
- Source is a price history and event analysis, not a full 15-section fundamental thesis
- Thesis sections 3, 10, 13, 14 are partially populated with estimates; full fundamental
  analysis requires earnings transcript / 10-K ingestion
- Key context established:
  - PG is -18% from 52-week high ($174.80) and +4.2% above 52-week low ($137.62)
  - 5-year price return: +16.1% vs. S&P 500 ~+65% — significant underperformance
  - Perfect storm: tariff headwinds ($1–1.5B/year), CEO transition, restructuring (7,000 cuts),
    4 consecutive below-consensus organic growth quarters
  - New CEO Jejurikar's debut Q2 FY2026 earnings: EPS $1.78 vs. $1.87 expected (miss)
  - Q3 FY2026 earnings (April 24, 2026) is the critical near-term test
  - Stock in 6-day losing streak and downtrend as of March 25, 2026

### Thesis Status
- **Overall**: Initiated — Watch / Conditional (insufficient data for full conviction)
- **BAIT delta**: Weak signal at initiation
  - B (Behavioral): MODERATE — fear has genuine fundamental support; not a pure overreaction
  - A (Analytical): WEAK-MODERATE — 20x P/E roughly fair for 0–4% growth; limited analytical edge
  - I (Informational): WEAK-MODERATE — no clearly under-appreciated informational edge identified
  - T (Technical): WEAK-MODERATE — downtrend, 6-day losing streak, Erste downgrade March 24
- **Price targets** (approximate, derived from valuation framework):
  - Bear: ~$125 (30% prob) | Base: ~$160 (45% prob) | Bull: ~$178 (25% prob)
  - Probability-weighted EV: ~$154 (~+7% price return + ~3% dividend = ~10% total)

### Action
- [ ] Buy more
- [ ] Trim
- [ ] Hold
- [x] Watch — wait for Q3 FY2026 (April 24, 2026) execution evidence before committing capital

Key question for Q3 FY2026: Does organic growth re-accelerate to 3–5%? Are restructuring
cost savings beginning to show in margins? Is the tariff headwind tracking within the $1B
guided range?

For income-oriented investors: $137–$143 range offers dividend yield support (~2.94–3.05%),
which is the highest since 2019. A small entry for yield capture at the 52-week low vicinity
is defensible. Full position building requires execution confirmation.

**Next review trigger**: Q3 FY2026 Earnings — April 24, 2026. This is the first meaningful
test under new CEO Jejurikar of the core thesis: can organic growth re-accelerate from the
0–1% range seen in Q2 FY2026 back to the 3–5% range required to justify 20x+ valuation?

**Data gap priority**: Ingest earnings transcript from Q3 FY2026 (April 24) to populate
full financials.md and complete the thesis sections currently marked [Needed].
